High levels of susceptibility to new and older antibiotics in : time to consider point-of-care or molecular testing for precision treatment?Neisseria gonorrhoeae: time to consider point-of-care or molecular testing for precision treatment? isolates from Saskatchewan (2003–15): time to consider point-of-care or molecular testing for precision treatment?

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

    loading  Loading Related Articles